|
|
|
|
| LEADER |
00000pam a22000004a 4500 |
| 001 |
5531622 |
| 003 |
ICU |
| 005 |
20050510191500.0 |
| 008 |
040320s2005 njua b 001 0 eng |
| 010 |
|
|
|a 2004006680
|
| 020 |
|
|
|a 1588292053 (alk. paper)
|
| 035 |
|
|
|a 2004006680
|
| 035 |
|
|
|a (DNLM)101210773
|
| 040 |
|
|
|a DNLM/DLC
|c DLC
|d DLC
|d UtOrBLW
|
| 042 |
|
|
|a pcc
|
| 050 |
0 |
0 |
|a RM666.A564
|b A585 2005
|
| 060 |
1 |
0 |
|a W1
|b ME9616JM v.106 2005
|
| 060 |
1 |
0 |
|a QU 57
|b A6332 2005
|
| 082 |
0 |
0 |
|a 615/.31
|2 22
|
| 245 |
0 |
0 |
|a Antisense therapeutics /
|c edited by M. Ian Phillips ; foreword by Stanley T. Crooke.
|
| 250 |
|
|
|a 2nd ed.
|
| 260 |
|
|
|a Totowa, N.J. :
|b Humana Press,
|c c2005.
|
| 300 |
|
|
|a xii, 327 p. :
|b ill. ;
|c 23 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 440 |
|
0 |
|a Methods in molecular medicine ;
|v 106
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Antisense therapeutics: a promise waiting to be fulfilled / Ian Phillips -- Antisense inhibition: oligonucleotides, ribozymes and siRNAs / Y. Clare Zhang ... [et al.] -- Local application of antisense for prevention of restenosis / Patrick L. Iversen ... [et al.] -- Antisense therapeutics for hypertension: targeting the renin/angiotensin system / M. Ian Phillips and Birgitta Kimura -- Antisense strategies for the treatment of heart failure / Sian E. Harding, Federica Del Monte, and Roger J. Hajjar -- Clinical studies of antisense oligonucleotides for cancer therapy / Rosanne M. Orr and F. Andrew Dorr -- Antisense therapy in clinical oncology: preclinical and clinical experiences / Ingo Tamm -- Radionucleide/peptide nucleic acid diagnosis and treatment of pancreatic cancer / Eric Wickstrom ... [et al.] -- Suppression of pancreatic and colon cancer cells by antisense K-RNA expression vectors / Kazunori Aoki, Shumpei Ohnami, and Teruhiko Yoshida -- Induction of tumor cell apoptosis and chemosensitization by antisense strategies / Manuel Rieber and Mary Strasberg-Rieber -- Utility of an anti-oncogene ribozymes and antisense oligonucletoides in reversing drug resistance / Tadao Funato -- Transport of antisense across the blood/brain barrier / Laura B. Jaeger and William A. Banks -- Transdermal delivery of antisense oligonucletoides / Rhonda M. Brand and Patrick L. Iversen -- Antisense strategies for redirection of drug metabolism: using paclitaxel as a model / Vikram Arora -- Antisense oligonucletoide treatment of inflammatory bowel diseases / Bruce R. Yacyshyn -- Optimizing electroporation conditions for the intracellular delivery of morpholino antisense oligonucleotides directed against the hepatitis C virus IRES / Ronald Jubin.
|
| 650 |
|
0 |
|a Antisense nucleic acids
|x Therapeutic use.
|
| 650 |
1 |
2 |
|a Oligonucleotides, Antisense
|x therapeutic use.
|
| 650 |
2 |
2 |
|a Oligonucleotides, Antisense
|x pharmacology.
|
| 650 |
|
7 |
|a Antisense nucleic acids
|x Therapeutic use.
|2 fast
|0 http://id.worldcat.org/fast/fst00810789
|
| 700 |
1 |
|
|a Phillips, M. Ian.
|0 http://id.loc.gov/authorities/names/n85273191
|1 http://viaf.org/viaf/113159866
|
| 903 |
|
|
|a HeVa
|
| 035 |
|
|
|a (OCoLC)54817592
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i 5a2dc8c2-9a43-5138-ab6f-78deaa20d394
|s 954ca44a-b3de-5bf6-8e2b-85ed1b0445b5
|
| 928 |
|
|
|t Library of Congress classification
|a RM666.A564 A585 2005
|l JCL
|c JCL-Sci
|i 4829457
|
| 927 |
|
|
|t Library of Congress classification
|a RM666.A564 A585 2005
|l JCL
|c JCL-Sci
|e VAND
|e CRERAR
|b 69638319
|i 7781080
|
